Chemotherapy for patients with pulmonary Kaposi's sarcoma: benefit of filgrastim (G-CSF) in supporting dose administration. [electronic resource]
Producer: 19931220Description: 1219-24 p. digitalISSN:- 0038-4348
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Lung Neoplasms -- drug therapy
- Neutropenia -- chemically induced
- Recombinant Proteins -- therapeutic use
- Sarcoma, Kaposi -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.